CQDM is joining forces with leaders across Canada’s life sciences ecosystem to reaffirm the importance of fostering an environment that supports innovation, growth, and the commercialization of research-driven breakthroughs.
At CQDM, we believe that collaboration is one of Canada’s greatest competitive advantages.
This joint call from leaders across the country’s life sciences ecosystem highlights the importance of connecting world-class science with the capital, partners, talent, and commercialization strategies needed to build global champions.
We’re proud to contribute to this conversation and, every day, to foster strategic collaborations between Canadian biotechs, leading academic researchers, global pharmaceutical companies, and support organizations. By bringing these stakeholders together, we aim to create the conditions for innovation to thrive and for Canada’s life sciences ecosystem to reach its full potential on the global stage.
Read the full op-ed 👉 click here!
Co-authored by Matthew Carlyle, President and CEO adMare BioInnovations; Maura Campbell, President and CEO OBIO); Jason Field, President and CEO Life Sciences Ontario; Benoit Larose Président-directeur general BIOQuébec; Wendy Hurlburt, President and CEO Life Sciences BC; Grace Lee Reynolds, CEO MaRS Discovery District; Prakash Gowd, Interim CEO TIAP – Toronto Innovation Acceleration Partners; Maxime Pesant, Vice-président, Placements privés et investissements d’impact | Sciences de la vie, Fonds de solidarité FTQ; Montréal InVivo and Véronique Dugas, Présidente et directrice Générale CQDM.
